Based on screening 52 cases (who had available extracted RNA matched with the DNA samples for further genotype-expression correlation analysis) and 104 controls, circulatory CDKN2B-AS1 was upregulated in cancer patients compared to controls (P < 0.001). Here, CDKN2B is linked to cancer.